This statistic shows the average life expectancy in North America for those born in 2022, by gender and region. In Canada, the average life expectancy was 80 years for males and 84 years for females.

Life expectancy in North America

Of those considered in this statistic, the life expectancy of female Canadian infants born in 2021 was the longest, at 84 years. Female infants born in America that year had a similarly high life expectancy of 81 years. Male infants, meanwhile, had lower life expectancies of 80 years (Canada) and 76 years (USA).

Compare this to the worldwide life expectancy for babies born in 2021: 75 years for women and 71 years for men. Of continents worldwide, North America ranks equal first in terms of life expectancy of (77 years for men and 81 years for women). Life expectancy is lowest in Africa at just 63 years and 66 years for males and females respectively. Japan is the country with the highest life expectancy worldwide for babies born in 2020.

Life expectancy is calculated according to current mortality rates of the population in question. Global variations in life expectancy are caused by differences in medical care, public health and diet, and reflect global inequalities in economic circumstances. Africa’s low life expectancy, for example, can be attributed in part to the AIDS epidemic. In 2019, around 72,000 people died of AIDS in South Africa, the largest amount worldwide. Nigeria, Tanzania and India were also high on the list of countries ranked by AIDS deaths that year. Likewise, Africa has by far the highest rate of mortality by communicable disease (i.e. AIDS, neglected tropics diseases, malaria and tuberculosis).

The life expectancy for men aged 65 years in the U.S. has gradually increased since the 1960s. Now men in the United States aged 65 can expect to live 18.2 more years on average. Women aged 65 years can expect to live around 20.7 more years on average. Life expectancy in the U.S. As of 2023, the average life expectancy at birth in the United States was 78.39 years. Life expectancy in the U.S. had steadily increased for many years but has recently dropped slightly. Women consistently have a higher life expectancy than men but have also seen a slight decrease. As of 2023, a woman in the U.S. could be expected to live up to 81.1 years. Leading causes of death The leading causes of death in the United States include heart disease, cancer, unintentional injuries, and cerebrovascular diseases. However, heart disease and cancer account for around 42 percent of all deaths. Although heart disease and cancer are the leading causes of death for both men and women, there are slight variations in the leading causes of death. For example, unintentional injury and suicide account for a larger portion of deaths among men than they do among women.

In 2023, a woman in the United States aged 65 years could expect to live another **** years on average. This number decreased in the years 2020 and 2021, after reaching a high of **** years in 2019. Nevertheless, the life expectancy of a woman aged 65 years in the United States is still higher than that of a man of that age. In 2023, a man aged 65 years could be expected to live another 18.2 years on average. Why has the life expectancy in the U.S. declined? Overall, life expectancy in the United States has declined in recent years. In 2019, the life expectancy for U.S. women was **** years, but by 2023 it had decreased to **** years. Likewise, the life expectancy for men decreased from **** years to **** years in the same period. The biggest contributors to this decline in life expectancy are the COVID-19 pandemic and the opioid epidemic. Although deaths from the COVID-19 pandemic have decreased significantly since 2022, deaths from opioid overdose continue to increase, reaching all-time highs in 2022. The leading causes of death among U.S. women The leading causes of death among women in the United States in 2022 were heart disease, cancer, stroke, and COVID-19. That year, heart disease and cancer accounted for a combined **** percent of all deaths among women, while around *** percent of deaths were due to COVID-19. The overall leading causes of death in the United States generally reflect the leading causes among women, with some slight variations. For example, Alzheimer’s disease is the ***** leading cause of death among women but the ******* leading cause of death overall in the United States.

The life expectancy of men at birth in the United States stood at 75.8 years in 2023. Between 1960 and 2023, the life expectancy rose by 9.2 years, though the increase followed an uneven trajectory rather than a consistent upward trend.

From the mid-19th century until today, life expectancy at birth in the United States has roughly doubled, from 39.4 years in 1850 to 79.6 years in 2025. It is estimated that life expectancy in the U.S. began its upward trajectory in the 1880s, largely driven by the decline in infant and child mortality through factors such as vaccination programs, antibiotics, and other healthcare advancements. Improved food security and access to clean water, as well as general increases in living standards (such as better housing, education, and increased safety) also contributed to a rise in life expectancy across all age brackets. There were notable dips in life expectancy; with an eight year drop during the American Civil War in the 1860s, a seven year drop during the Spanish Flu empidemic in 1918, and a 2.5 year drop during the Covid-19 pandemic. There were also notable plateaus (and minor decreases) not due to major historical events, such as that of the 2010s, which has been attributed to a combination of factors such as unhealthy lifestyles, poor access to healthcare, poverty, and increased suicide rates, among others. However, despite the rate of progress slowing since the 1950s, most decades do see a general increase in the long term, and current UN projections predict that life expectancy at birth in the U.S. will increase by another nine years before the end of the century.

In 2024, the average life expectancy in the world was 71 years for men and 76 years for women. The lowest life expectancies were found in Africa, while Oceania and Europe had the highest. What is life expectancy?Life expectancy is defined as a statistical measure of how long a person may live, based on demographic factors such as gender, current age, and most importantly the year of their birth. The most commonly used measure of life expectancy is life expectancy at birth or at age zero. The calculation is based on the assumption that mortality rates at each age were to remain constant in the future. Life expectancy has changed drastically over time, especially during the past 200 years. In the early 20th century, the average life expectancy at birth in the developed world stood at 31 years. It has grown to an average of 70 and 75 years for males and females respectively, and is expected to keep on growing with advances in medical treatment and living standards continuing. Highest and lowest life expectancy worldwide Life expectancy still varies greatly between different regions and countries of the world. The biggest impact on life expectancy is the quality of public health, medical care, and diet. As of 2022, the countries with the highest life expectancy were Japan, Liechtenstein, Switzerland, and Australia, all at 84–83 years. Most of the countries with the lowest life expectancy are mostly African countries. The ranking was led by the Chad, Nigeria, and Lesotho with 53–54 years.

The impact of rising drug use on US mortality may extend beyond deaths coded as drug-related to include excess mortality from other causes affected by drug use. Here, we estimate the full extent of drug-associated mortality. We use annual death rates for 1999–2016 by state, sex, five-year age group, and cause of death to model the relationship between drug-coded mortality—which serves as an indicator of the population-level prevalence of drug use—and mortality from other causes. Among residents aged 15–64 living in the 50 US states, the estimated number of drug-associated deaths in 2016 (141,695) was 2.2 times the number of drug-coded deaths (63,000). Adverse trends since 2010 in midlife mortality are largely attributable to drug-associated mortality. In the absence of drug use, we estimate that the probability of dying between ages 15 and 65 would have continued to decline after 2010 among men (to 15% in 2016) and would have remained at a low level (10%) among women. Our results suggest that an additional 3.9% of men and 1.8% of women died between ages 15 and 65 in 2016 because of drug use. In terms of life expectancy beyond age 15, we estimate that drug use cost men 1.4 years and women 0.7 years, on average. In the hardest-hit state (West Virginia), drug use cost men 3.6 and women 1.9 life years. Recent declines in US life expectancy have been blamed largely on the drug epidemic. Consistent with that inference, our results imply that, in the absence of drug use, life expectancy at age 15 would have increased slightly between 2014 and 2016. Drug-associated mortality in the US is roughly double that implied by drug-coded deaths alone. The drug epidemic is exacting a heavy cost to American lives, not only from overdoses but from a variety of causes.

United States US: Life Expectancy at Birth: Total data was reported at 78.690 Year in 2016. This stayed constant from the previous number of 78.690 Year for 2015. United States US: Life Expectancy at Birth: Total data is updated yearly, averaging 74.766 Year from Dec 1960 (Median) to 2016, with 57 observations. The data reached an all-time high of 78.841 Year in 2014 and a record low of 69.771 Year in 1960. United States US: Life Expectancy at Birth: Total data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s United States – Table US.World Bank.WDI: Health Statistics. Life expectancy at birth indicates the number of years a newborn infant would live if prevailing patterns of mortality at the time of its birth were to stay the same throughout its life.; ; (1) United Nations Population Division. World Population Prospects: 2017 Revision, or derived from male and female life expectancy at birth from sources such as: (2) Census reports and other statistical publications from national statistical offices, (3) Eurostat: Demographic Statistics, (4) United Nations Statistical Division. Population and Vital Statistics Reprot (various years), (5) U.S. Census Bureau: International Database, and (6) Secretariat of the Pacific Community: Statistics and Demography Programme.; Weighted average;

BackgroundCombination antiretroviral therapy (ART) has significantly increased survival among HIV-positive adults in the United States (U.S.) and Canada, but gains in life expectancy for this region have not been well characterized. We aim to estimate temporal changes in life expectancy among HIV-positive adults on ART from 2000–2007 in the U.S. and Canada.MethodsParticipants were from the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD), aged ≥20 years and on ART. Mortality rates were calculated using participants' person-time from January 1, 2000 or ART initiation until death, loss to follow-up, or administrative censoring December 31, 2007. Life expectancy at age 20, defined as the average number of additional years that a person of a specific age will live, provided the current age-specific mortality rates remain constant, was estimated using abridged life tables.ResultsThe crude mortality rate was 19.8/1,000 person-years, among 22,937 individuals contributing 82,022 person-years and 1,622 deaths. Life expectancy increased from 36.1 [standard error (SE) 0.5] to 51.4 [SE 0.5] years from 2000–2002 to 2006–2007. Men and women had comparable life expectancies in all periods except the last (2006–2007). Life expectancy was lower for individuals with a history of injection drug use, non-whites, and in patients with baseline CD4 counts

Mexico MX: Life Expectancy at Birth: Total data was reported at 77.305 Year in 2017. This records an increase from the previous number of 77.118 Year for 2016. Mexico MX: Life Expectancy at Birth: Total data is updated yearly, averaging 70.239 Year from Dec 1960 (Median) to 2017, with 58 observations. The data reached an all-time high of 77.305 Year in 2017 and a record low of 57.082 Year in 1960. Mexico MX: Life Expectancy at Birth: Total data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Mexico – Table MX.World Bank.WDI: Health Statistics. Life expectancy at birth indicates the number of years a newborn infant would live if prevailing patterns of mortality at the time of its birth were to stay the same throughout its life.; ; (1) United Nations Population Division. World Population Prospects: 2017 Revision, or derived from male and female life expectancy at birth from sources such as: (2) Census reports and other statistical publications from national statistical offices, (3) Eurostat: Demographic Statistics, (4) United Nations Statistical Division. Population and Vital Statistics Reprot (various years), (5) U.S. Census Bureau: International Database, and (6) Secretariat of the Pacific Community: Statistics and Demography Programme.; Weighted average;

This table contains 2394 series, with data for years 1991 -1991 (not all combinations necessarily have data for all years). This table contains data described by the following dimensions (Not all combinations are available): Geography (1 items: Canada ...), Population group (19 items: Entire cohort; Income adequacy quintile 1 (lowest);Income adequacy quintile 3;Income adequacy quintile 2 ...), Age (14 items: At 25 years; At 30 years; At 35 years; At 40 years ...), Sex (3 items: Both sexes; Females; Males ...), Characteristics (3 items: Probability of survival; Low 95% confidence interval; life expectancy; High 95% confidence interval; life expectancy ...).

In 1970, women born in the U.S. could expect to live for 1.3 years more than women in the Soviet Union, and men in the U.S. could expect to live for 2.7 years longer than their Soviet counterparts. U.S. figures would steadily increase over the following decade, whereas the economic decline of the Soviet Union would see life expectancy fall by two years for men and 0.8 years for women. In 1980, the difference in life expectancy from birth between the two countries was 7.5 years for men, and 4.8 years for women. This difference has largely been attributed to an increase in alcohol and substance abuse and accidental deaths among males in the Soviet Union, as well as more accurate reporting methods in the Soviet Union (suggesting that early figures may no be fully representational). Although Soviet life expectancy did increase in the 1980s, the gap between life expectancy there and in the U.S. remained significantly larger than in 1970, and this trend continued well into the 1990s and early-2000s as the post-Soviet states adjusted to the socio-economic impact of the Union's dissolution.

Similar Datasets

• Company Bankruptcy Prediction: LINK
• The Boston House-Price Data: LINK
• California Housing Prices Data (5 new features!): LINK
• Spanish Wine Quality Dataset: LINK

Context

The gender pay gap or gender wage gap is the average difference between the remuneration for men and women who are working. Women are generally considered to be paid less than men. There are two distinct numbers regarding the pay gap: non-adjusted versus adjusted pay gap. The latter typically takes into account differences in hours worked, occupations were chosen, education, and job experience. In the United States, for example, the non-adjusted average female's annual salary is 79% of the average male salary, compared to 95% for the adjusted average salary.

The reasons link to legal, social, and economic factors, and extend beyond "equal pay for equal work".

The gender pay gap can be a problem from a public policy perspective because it reduces economic output and means that women are more likely to be dependent upon welfare payments, especially in old age.

This dataset aims to replicate the data used in the famous paper "The Gender Wage Gap: Extent, Trends, and Explanations", which provides new empirical evidence on the extent of and trends in the gender wage gap, which declined considerably during the 1980–2010 period.

Citation

fedesoriano. (January 2022). Gender Pay Gap Dataset. Retrieved [Date Retrieved] from https://www.kaggle.com/fedesoriano/gender-pay-gap-dataset.

Content

There are 2 files in this dataset: a) the Panel Study of Income Dynamics (PSID) microdata over the 1980-2010 period, and b) the Current Population Survey (CPS) to provide some additional US national data on the gender pay gap.

PSID variables:

NOTES: THE VARIABLES WITH fz ADDED TO THEIR NAME REFER TO EXPERIENCE WHERE WE HAVE FILLED IN SOME ZEROS IN THE MISSING PSID YEARS WITH DATA FROM THE RESPONDENTS’ ANSWERS TO QUESTIONS ABOUT JOBS WORKED ON DURING THESE MISSING YEARS. THE fz variables WERE USED IN THE REGRESSION ANALYSES THE VARIABLES WITH A predict PREFIX REFER TO THE COMPUTATION OF ACTUAL EXPERIENCE ACCUMULATED DURING THE YEARS IN WHICH THE PSID DID NOT SURVEY THE RESPONDENTS. THERE ARE MORE PREDICTED EXPERIENCE LEVELS THAT ARE NEEDED TO IMPUTE EXPERIENCE IN THE MISSING YEARS IN SOME CASES. NOTE THAT THE VARIABLES yrsexpf, yrsexpfsz, etc., INCLUDE THESE COMPUTATIONS, SO THAT IF YOU WANT TO USE FULL TIME OR PART TIME EXPERIENCE, YOU DON’T NEED TO ADD THESE PREDICT VARIABLES IN. THEY ARE INCLUDED IN THE DATA SET TO ILLUSTRATE THE RESULTS OF THE COMPUTATION PROCESS. THE VARIABLES WITH AN orig PREFIX ARE THE ORIGINAL PSID VARIABLES. THESE HAVE BEEN PROCESSED AND IN SOME CASES RENAMED FOR CONVENIENCE. THE hd SUFFIX MEANS THAT THE VARIABLE REFERS TO THE HEAD OF THE FAMILY, AND THE wf SUFFIX MEANS THAT IT REFERS TO THE WIFE OR FEMALE COHABITOR IF THERE IS ONE. AS SHOWN IN THE ACCOMPANYING REGRESSION PROGRAM, THESE orig VARIABLES AREN’T USED DIRECTLY IN THE REGRESSIONS. THERE ARE MORE OF THE ORIGINAL PSID VARIABLES, WHICH WERE USED TO CONSTRUCT THE VARIABLES USED IN THE REGRESSIONS. HD MEANS HEAD AND WF MEANS WIFE OR FEMALE COHABITOR.

1. intnum68: 1968 INTERVIEW NUMBER
2. pernum68: PERSON NUMBER 68
3. wave: Current Wave of the PSID
4. sex: gender SEX OF INDIVIDUAL (1=male, 2=female)
5. intnum: Wave-specific Interview Number
6. farminc: Farm Income
7. region: regLab Region of Current Interview
8. famwgt: this is the PSID’s family weight, which is used in all analyses
9. relhead: ER34103L this is the relation to the head of household (10=head; 20=legally married wife; 22=cohabiting partner)
10. age: Age
11. employed: ER34116L Whether or not employed or on temp leave (everyone gets a 1 for this variable, since our wage analyses use only the currently employed)
12. sch: schLbl Highest Year of Schooling
13. annhrs: Annual Hours Worked
14. annlabinc: Annual Labor Income
15. occ: 3 Digit Occupation 2000 codes
16. ind: 3 Digit Industry 2000 codes
17. white: White, nonhispanic dummy variable
18. black: Black, nonhispanic dummy variable
19. hisp: Hispanic dummy variable
20. othrace: Other Race dummy variable
21. degree: degreeLbl Agent's Degree Status (0=no college degree; 1=bachelor’s without advanced degree; 2=advanced degree)
22. degupd: degreeLbl Agent's Degree Status (Updated with 2009 values)
23. schupd: schLbl Schooling (updated years of schooling)
24. annwks: Annual Weeks Worked
25. unjob: unJobLbl Union Coverage dummy variable
26. usualhrwk: Usual Hrs Worked Per Week
27. labincbus: Labor Income from...

IntroductionTenofovir (TDF)-containing PrEP is effective for HIV prevention, but its effect on health-related quality of life (QOL) is unknown. Using data from HPTN 069/ACTG A5305, a randomized study of potential PrEP regimens comparing maraviroc alone, or together with TDF or emtricitabine (FTC), to TDF + FTC (control), we evaluated the impact of these regimens on QOL in at-risk HIV-uninfected U.S. women and men.MethodsQOL was measured at baseline (before starting medications) and every 8 weeks through week 48 using the EQ-5D-3L. Responses were converted to a scale from 0.0 (death) to 1.0 (perfect health), using published valuation weights. Mean scores were compared between groups at each time point using nonparametric testing. Multivariable linear regression was used to adjust for potential confounders.ResultsWe analyzed 186 women (median age 35 years, 65% black, 17% Hispanic) and 405 men (median age 30 years, 28% black, 22% Hispanic), including 9 transgender participants analyzed based on sex-at-birth. Mean baseline QOL was 0.91 for women and 0.95 for men. There were minimal changes in mean QOL over time for any regimen (women: p = 0.29; men: p = 0.14). There were no significant differences between participants who continued the regimen compared to participants who discontinued early (women: p = 0.61; men: p = 0.1). Mean QOL did not differ significantly by regimen at any time point, both unadjusted and after adjustment for age, race/ethnicity, adherence, and use of alcohol, marijuana, opiates, and other substances.ConclusionsQOL in at-risk individuals starting candidate PrEP regimens in a clinical trial is similar to the general population and maintained over time. This finding did not vary among regimens or when adjusted for demographics, adherence, and substance use. Our findings are the first to show that starting a candidate PrEP regimen in at-risk HIV-uninfected U.S. women and men was not associated with significant changes in QOL.Trial registrationClinicaltrials.gov NCT01505114.

Abstract

The 1998 Kenya Demographic and Health Survey (KDHS) is a nationally representative survey of 7,881 wo 881 women age 15-49 and 3,407 men age 15-54. The KDHS was implemented by the National Council for Population and Development (NCPD) and the Central Bureau of Statistics (CBS), with significant technical and logistical support provided by the Ministry of Health and various other governmental and nongovernmental organizations in Kenya. Macro International Inc. of Calverton, Maryland (U.S.A.) provided technical assistance throughout the course of the project in the context of the worldwide Demographic and Health Surveys (DHS) programme, while financial assistance was provided by the U.S. Agency for International Development (USAID/Nairobi) and the Department for International Development (DFID/U.K.). Data collection for the KDHS was conducted from February to July 1998. Like the previous KDHS surveys conducted in 1989 and 1993, the 1998 KDHS was designed to provide information on levels and trends in fertility, family planning knowledge and use, infant and child mortality, and other maternal and child health indicators. However, the 1998 KDHS went further to collect more in-depth data on knowledge and behaviours related to AIDS and other sexually transmitted diseases (STDs), detailed “calendar” data that allows estimation of contraceptive discontinuation rates, and information related to the practice of female circumcision. Further, unlike earlier surveys, the 1998 KDHS provides a national estimate of the level of maternal mortality (i.e. related to pregnancy and childbearing).The KDHS data are intended for use by programme managers and policymakers to evaluate and improve health and family planning programmes in Kenya. Fertility. The survey results demonstrate a continuation of the fertility transition in Kenya. At current fertility levels, a Kenyan women will bear 4.7 children in her life, down 30 percent from the 1989 KDHS when the total fertility rate (TFR) was 6.7 children, and 42 percent since the 1977/78 Kenya Fertility Survey (KFS) when the TFR was 8.1 children per woman. A rural woman can expect to have 5.2 children, around two children more than an urban women (3.1 children). Fertility differentials by women's education level are even more remarkable; women with no education will bear an average of 5.8 children, compared to 3.5 children for women with secondary school education. Marriage. The age at which women and men first marry has risen slowly over the past 20 years. Currently, women marry for the first time at an average age of 20 years, compared with 25 years for men. Women with a secondary education marry five years later (22) than women with no education (17).The KDHS data indicate that the practice of polygyny continues to decline in Kenya. Sixteen percent of currently married women are in a polygynous union (i.e., their husband has at least one other wife), compared with 19 percent of women in the 1993 KDHS, 23 percent in the 1989 KDHS, and 30 percent in the 1977/78 KFS. While men first marry an average of 5 years later than women, men become sexual active about onehalf of a year earlier than women; in the youngest age cohort for which estimates are available (age 20-24), first sex occurs at age 16.8 for women and 16.2 for men. Fertility Preferences. Fifty-three percent of women and 46 percent of men in Kenya do not want to have any more children. Another 25 percent of women and 27 percent of men would like to delay their next child for two years or longer. Thus, about three-quarters of women and men either want to limit or to space their births. The survey results show that, of all births in the last three years, 1 in 10 was unwanted and 1 in 3 was mistimed. If all unwanted births were avoided, the fertility rate in Kenya would fall from 4.7 to 3.5 children per woman. Family Planning. Knowledge and use of family planning in Kenya has continued to rise over the last several years. The 1998 KDHS shows that virtually all married women (98 percent) and men (99 percent) were able to cite at least one modern method of contraception. The pill, condoms, injectables, and female sterlisation are the most widely known methods. Overall, 39 percent of currently married women are using a method of contraception. Use of modern methods has increased from 27 in the 1993 KDHS to 32 percent in the 1998 KDHS. Currently, the most widely used methods are contraceptive injectables (12 percent of married women), the pill (9 percent), female sterilisation (6 percent), and periodic abstinence (6 percent). Three percent of married women are using the IUD, while over 1 percent report using the condom and 1 percent use of contraceptive implants (Norplant). The rapid increase in use of injectables (from 7 to 12 percent between 1993 and 1998) to become the predominant method, plus small rises in the use of implants, condoms and female sterilisation have more than offset small decreases in pill and IUD use. Thus, both new acceptance of contraception and method switching have characterised the 1993-1998 intersurvey period. Contraceptive use varies widely among geographic and socioeconomic subgroups. More than half of currently married women in Central Province (61 percent) and Nairobi Province (56 percent) are currently using a method, compared with 28 percent in Nyanza Province and 22 percent in Coast Province. Just 23 percent of women with no education use contraception versus 57 percent of women with at least some secondary education. Government facilities provide contraceptives to 58 percent of users, while 33 percent are supplied by private medical sources, 5 percent through other private sources, and 3 percent through community-based distribution (CBD) agents. This represents a significant shift in sourcing away from public outlets, a decline from 68 percent estimated in the 1993 KDHS. While the government continues to provide about two-thirds of IUD insertions and female sterilisations, the percentage of pills and injectables supplied out of government facilities has dropped from over 70 percent in 1993 to 53 percent for pills and 64 percent for injectables in 1998. Supply of condoms through public sector facilities has also declined: from 37 to 21 percent between 1993 and 1998. The survey results indicate that 24 percent of married women have an unmet need for family planning (either for spacing or limiting births). This group comprises married women who are not using a method of family planning but either want to wait two year or more for their next birth (14 percent) or do not want any more children (10 percent). While encouraging that unmet need at the national level has declined (from 34 to 24 percent) since 1993, there are parts of the country where the need for contraception remains high. For example, the level of unmet need is higher in Western Province (32 percent) and Coast Province (30 province) than elsewhere in Kenya. Early Childhood Mortality. One of the main objectives of the KDHS was to document current levels and trends in mortality among children under age 5. Results from the 1998 KDHS data make clear that childhood mortality conditions have worsened in the early-mid 1990s; this after a period of steadily improving child survival prospects through the mid-to-late 1980s. Under-five mortality, the probability of dying before the fifth birthday, stands at 112 deaths per 1000 live births which represents a 24 percent increase over the last decade. Survival chances during age 1-4 years suffered disproportionately: rising 38 percent over the same period. Survey results show that childhood mortality is especially high when associated with two factors: a short preceding birth interval and a low level of maternal education. The risk of dying in the first year of life is more than doubled when the child is born after an interval of less than 24 months. Children of women with no education experience an under-five mortality rate that is two times higher than children of women who attended secondary school or higher. Provincial differentials in childhood mortality are striking; under-five mortality ranges from a low of 34 deaths per 1000 live births in Central Province to a high of 199 per 1000 in Nyanza Province. Maternal Health. Utilisation of antenatal services is high in Kenya; in the three years before the survey, mothers received antenatal care for 92 percent of births (Note: These data do not speak to the quality of those antenatal services). The median number of antenatal visits per pregnancy was 3.7. Most antenatal care is provided by nurses and trained midwives (64 percent), but the percentage provided by doctors (28 percent) has risen in recent years. Still, over one-third of women who do receive care, start during the third trimester of pregnancy-too late to receive the optimum benefits of antenatal care. Mothers reported receiving at least one tetanus toxoid injection during pregnancy for 90 percent of births in the three years before the survey. Tetanus toxoid is a powerful weapon in the fight against neonatal tetanus, a deadly disease that attacks young infants. Forty-two percent of births take place in health facilities; however, this figure varies from around three-quarters of births in Nairobi to around one-quarter of births in Western Province. It is important for the health of both the mother and child that trained medical personnel are available in cases of prolonged labour or obstructed delivery, which are major causes of maternal morbidity and mortality. The 1998 KDHS collected information that allows estimation of mortality related to pregnancy and childbearing. For the 10-year period before the survey, the maternal mortality ratio was estimated to be 590 deaths per 100,000 live births. Bearing on average 4.7 children, a Kenyan woman has a 1 in 36 chance of dying from maternal causes during her lifetime. Childhood Immunisation. The KDHS

Over the past 75 years, women have generally had a higher life expectancy than men by around 4-6 years. Reasons for this difference include higher susceptibility to childhood diseases among males; higher rates of accidental deaths, conflict-related deaths, and suicide among adult men; and higher prevalence of unhealthy lifestyle habits and chronic illnesses, as well as higher susceptibility to chronic diseases among men. Therefore, men not only have lower life expectancy than women overall, but also throughout each stage of life. Throughout the given period, there were notable dips in life expectancy for both sexes, including a roughly four year drop in 1960 due to China's so-called Great Leap Forward, and a 1.8 year drop due to the Covid-19 pandemic in 2021. Across the world, differences in life expectancy can vary between the sexes by large margins. In countries such as the Nordics, for example, the difference is low due to high-quality healthcare systems and access, as well as high quality diets and lifestyles. In Eastern Europe, however, the difference is over 10 years in Russia and Ukraine due to the war, although the differences were already very pronounced in this region before 2022, in large part driven by unhealthier lifestyles among men.

As of 2023, the countries with the highest life expectancy included Switzerland, Japan, and Spain. As of that time, a new-born child in Switzerland could expect to live an average of **** years. Around the world, females consistently have a higher average life expectancy than males, with females in Europe expected to live an average of *** years longer than males on this continent. Increases in life expectancy The overall average life expectancy in OECD countries increased by **** years from 1970 to 2019. The countries that saw the largest increases included Turkey, India, and South Korea. The life expectancy at birth in Turkey increased an astonishing 24.4 years over this period. The countries with the lowest life expectancy worldwide as of 2022 were Chad, Lesotho, and Nigeria, where a newborn could be expected to live an average of ** years. Life expectancy in the U.S. The life expectancy in the United States was ***** years as of 2023. Shockingly, the life expectancy in the United States has decreased in recent years, while it continues to increase in other similarly developed countries. The COVID-19 pandemic and increasing rates of suicide and drug overdose deaths from the opioid epidemic have been cited as reasons for this decrease.

The life expectancy experiences significant growth in all gender groups in 2023. As part of the positive trend, the life expectancy reaches the maximum value for the different genders at the end of the comparison period. Particularly noteworthy is the life expectancy of women at birth, which has the highest value of 79.11 years. Life expectancy at birth refers to the number of years the average newborn is expected to live, providing that mortality patterns at the time of birth do not change thereafter.Find further similar statistics for other countries or regions like Gabon and Grenada.

A global phenomenon, known as the demographic transition, has seen life expectancy from birth increase rapidly over the past two centuries. In pre-industrial societies, the average life expectancy was around 24 years, and it is believed that this was the case throughout most of history, and in all regions. The demographic transition then began in the industrial societies of Europe, North America, and the West Pacific around the turn of the 19th century, and life expectancy rose accordingly. Latin America was the next region to follow, before Africa and most Asian populations saw their life expectancy rise throughout the 20th century.

In 1970, life expectancy at birth in the Soviet Union and United States was fairly similar, at 69.3 and 70.8 years respectively; a difference of 1.5 years. As the decades progressed, however, this difference widened. While improvements in the recording of such statistics in the Soviet Union gave a more reliable picture of life expectancy across the region, especially in Central Asia and rural areas, the largest influence was due to the side-effects of deteriorating economic conditions. As lifestyles and medical care in the U.S. steadily improved, the decline in life expectancy the USSR was largely due to preventable causes, particularly alcoholism and accidental deaths among the male population. By 1985, life expectancy in the U.S. was 6.3 years higher than in the Soviet Union.

When looking at each gender, life expectancy among women in the U.S. in 1985 was seven years higher than men, whereas there was a difference of almost 10 years in the USSR. Women in the U.S. could also expect to live for five years longer than their Soviet counterparts in this year, while life expectancy among men in the U.S. was eight years higher than in the USSR. Overall, the gap between the two countries narrowed in the late 1980s as the Soviet Union's existence came to an end, however, this gap then grew even larger throughout most of the 1990s and early-2000s, and the post-Soviet states continue to deal with the social and economic legacy of Soviet dissolution on their respective demographics thirty years later.